Teng-Yu Lee

17PUBLICATIONS
12CO-AUTHORS
Gene and molecular therapyMedical biochemistry - proteins and peptides (incl. medical proteomics)Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 27, 2026
Tenofovir Alafenamide Versus Entecavir as Switch Therapy After Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B.

|Jan 28, 2026
Serum Outperforms Plasma for Glypican-3 Quantification in Hepatocellular Carcinoma-A Prospective Comparative Study.

Ming-Tze Yang, Jiunn-Min Wang, Chen-Shiou Wu

|Sep 27, 2025
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on Immunotherapy.

Shou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin

|May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort Study.

Shih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li

|May 11, 2024
The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma.

Shou-Wu Lee, Teng-Yu Lee, Sheng-Shun Yang

|Dec 23, 2023
Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients.

Yi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen

Pageof 3

Frequent Collaborators

7 joint publications

Teng-Yu Lee

3 joint publications

Hsin-Ju Tsai

2 joint publications

Yen-Chun Peng

2 joint publications

Yi-Hsiang Huang